Mansour Riachi
Appearances
- DateMay 6, 2023Management of patients with margin negative, T1-T3, N0 (stage IB–IIIA), resected gallbladder cancer (GBC) remains poorly defined. Current guidelines consider observation, chemotherapy (CT), and chemoradiation (CRT) as options…
- DateMay 20, 2024The majority of pancreatic ductal adenocarcinoma (PDAC) patients are metastatic at presentation with limited treatment options and a poor overall 5-year survival of 3%. The liver is the predominant site of distant metastasis in PDAC…
- DateMay 18, 2024
Presenter
- DateMay 18, 2024RISK FACTORS FOR REGROWTH AFTER NONOPERATIVE MANAGEMENT FOR RECTAL CANCER
Moderators
Stony Brook University Hospital
Cleveland Clinic
University of Wisconsin-Madison
University of Alabama at Birmingham (UAB)Speakers
Massachusetts General Hospital

